Thought Leader Select Announces New Assessments of Key Opinion Leaders, Centers of Excellence in Women’s Health, Oncology

Company News

Thought Leader Select is pleased to announce a pair of projects in support of a top 10 global biopharmaceutical company as it seeks to develop a portfolio of medicines in women’s health.

For the assessments, Thought Leader Select will study key opinion leaders and medical centers of excellence in the treatment of cancers affecting the gynecological health of women, specifically ovarian cancer, cervical cancer, and uterine cancer. In the first assessment, the company will identify and profile Canadian oncologists with vast expertise in research and treatment of these cancers affecting women.  In the second assessment, Thought Leader Select will identify and profile Canadian medical centers with specialized infrastructures for research and treatment in these disease areas.

“We are very proud to begin this critical work supporting pharmaceutical development in the area of women’s health,” stated Neil Mellor, Thought Leader Select’s global business development consultant.  “This client is an established leader in developing medicines for the treatment of various forms of cancer, and we appreciate the opportunity to help them partner with the right key opinion leaders and centers of excellence in women’s health and oncology, to ultimately help patients suffering from these cancers.”

More Posts


Send Us A Message